BackOramed Pharmaceuticals Overview

Oramed Pharmaceuticals Current Assets

Oramed Pharmaceuticals's current assets is $53M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$53.41M
46.07% YoYΔ $-45.62M vs prior year quarter

Peer trimmed avg / median

Loading

Oramed Pharmaceuticals Current Assets History

Loading

Oramed Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Oramed Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Oramed Pharmaceuticals (ORMP) FAQ

As of the most recent data (June 2026), ORMP shows a current assets of $53M. That compares with $99M in the prior-year period — down 46.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORMP's current assets is now $53M (was $99M) — a 46.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Oramed Pharmaceuticals is outperforming or lagging.

Tracking ORMP's current assets over time shows whether Oramed Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $53M That compares with $99M in the prior-year period — down 46.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Oramed Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $53M) with ownership activity and broader fundamentals.

Oramed Pharmaceuticals's current assets is $53M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.